Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French Center.


Journal

Journal of gastrointestinal and liver diseases : JGLD
ISSN: 1842-1121
Titre abrégé: J Gastrointestin Liver Dis
Pays: Romania
ID NLM: 101272825

Informations de publication

Date de publication:
28 Sep 2023
Historique:
received: 10 11 2022
accepted: 20 05 2023
medline: 29 9 2023
pubmed: 29 9 2023
entrez: 29 9 2023
Statut: epublish

Résumé

Colorectal lesions measuring greater than 20 mm are unsuitable for en bloc endoscopic mucosal resection (EMR): piecemeal EMR (PM-EMR) and endoscopic submucosal dissection (ESD) are needed. The European Society of Gastrointestinal Endoscopy (ESGE) recommends ESD only for microinfiltrative lesions, although Japanese teams perform en bloc ESD for all lesions. We report the outcomes obtained in our endoscopy unit for these lesions and assess the hybrid "knife-assisted piecemeal EMR" (KAPM-EMR) technique. The main aim was to assess the short-term outcomes (C1). The secondary objectives were to evaluate the long-term results (C2), adverse event rate and management of recurrence. We retrospectively analyzed data from patients treated by PM-EMR, KAPM-EMR and ESD for a colorectal lesion measuring greater than 20 millimeters using prospective inclusion over four years. Data from 167 patients (median age: 70) with a median follow-up of 15.1 months were analyzed after excluding 95 patients. A total of 131 lesions were removed by PM-EMR, 24 by KAPM-EMR and 12 by ESD; 146/167 (87.4%) patients were considered in remission at C1. Recurrence was treated by endoscopy in 20/21 patients (95%); 86/89 (96.6%) were in remission at C2. A total of 16/167 patients developed adverse events, all of whom except one were endoscopically managed. KAPM-EMR was associated with a higher perforation risk (p=0.037). No differences in postoperative bleeding were found among the three groups (p=0.576). Piecemeal resection remains an effective and safe technique for large colorectal adenomas. KAPM-EMR may be useful but should be applied with caution due to the risk of perforation.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Colorectal lesions measuring greater than 20 mm are unsuitable for en bloc endoscopic mucosal resection (EMR): piecemeal EMR (PM-EMR) and endoscopic submucosal dissection (ESD) are needed. The European Society of Gastrointestinal Endoscopy (ESGE) recommends ESD only for microinfiltrative lesions, although Japanese teams perform en bloc ESD for all lesions. We report the outcomes obtained in our endoscopy unit for these lesions and assess the hybrid "knife-assisted piecemeal EMR" (KAPM-EMR) technique. The main aim was to assess the short-term outcomes (C1). The secondary objectives were to evaluate the long-term results (C2), adverse event rate and management of recurrence.
METHODS METHODS
We retrospectively analyzed data from patients treated by PM-EMR, KAPM-EMR and ESD for a colorectal lesion measuring greater than 20 millimeters using prospective inclusion over four years.
RESULTS RESULTS
Data from 167 patients (median age: 70) with a median follow-up of 15.1 months were analyzed after excluding 95 patients. A total of 131 lesions were removed by PM-EMR, 24 by KAPM-EMR and 12 by ESD; 146/167 (87.4%) patients were considered in remission at C1. Recurrence was treated by endoscopy in 20/21 patients (95%); 86/89 (96.6%) were in remission at C2. A total of 16/167 patients developed adverse events, all of whom except one were endoscopically managed. KAPM-EMR was associated with a higher perforation risk (p=0.037). No differences in postoperative bleeding were found among the three groups (p=0.576).
CONCLUSIONS CONCLUSIONS
Piecemeal resection remains an effective and safe technique for large colorectal adenomas. KAPM-EMR may be useful but should be applied with caution due to the risk of perforation.

Identifiants

pubmed: 37774222
doi: 10.15403/jgld-4719
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

315-322

Auteurs

Jean-Philippe Ratone (JP)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. jpratone@hotmail.fr.

Clément Archimbaud (C)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. clementarchimbaud@gmail.com.

Alexey Solovyev (A)

Paoli-Calmettes Institute, Dept Clin Res and Invest, Biostat and Methodolo Unit, Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France. solovyeva@ipc.unicancer.fr.

Christophe Zemmour (C)

Paoli-Calmettes Institute, Dept Clin Res and Invest, Biostat and Methodolo Unit, Marseille, France. zemmourc@ipc.unicancer.fr.

Christian Pesenti (C)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. pesentic@ipc.unicancer.fr.

Solène Hoibian (S)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. solene.hoibian@hotmail.fr.

Yanis Dahel (Y)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. dahely@ipc.unicancer.fr.

Mariola Marx (M)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. mariolamarx@gmx.de.

Cécile De Chaisemartin (C)

Paoli-Calmettes Institute, Surgical Unit, Marseille, France. dechaisemartinc@ipc.unicancer.fr.

Brice Chanez (B)

Paoli-Calmettes Institute, Digestive Oncology Unit, Marseille, France. chanezb@ipc.unicancer.fr.

Hélène Meillat (H)

Paoli-Calmettes Institute, Surgical Unit, Marseille, France. meillath@ipc.unicancer.fr.

Bernard Lelong (B)

Paoli-Calmettes Institute, Surgical Unit, Marseille, France. lelongb@ipc.unicancer.fr.

Flora Poizat (F)

Paoli-Calmettes Institute, Pathology Unit, Marseille, France. poizatf@ipc.unicancer.fr.

Fabrice Caillol (F)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. fcaillol@free.fr.

Marc Giovannini (M)

Paoli-Calmettes Institute, Endoscopy Unit, Marseille, France. giovanninim@ipc.unicancer.fr.

Classifications MeSH